Literature DB >> 11986344

Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

V Speirs1, G P Skliris, S E Burdall, P J Carder.   

Abstract

AIM: Two oestrogen receptors (ERs) have been identified to date-the "classic" ER alpha and the more recently described ER beta. Although much is known about ER alpha at the mRNA and protein levels, our knowledge of the expression and distribution of ER beta protein is much more limited. The aim of this study was to compare the cellular distribution of ER alpha and ER beta in normal human mammary gland.
METHODS: Formalin fixed, paraffin wax embedded material was obtained from reduction mammoplasty specimens, normal tissue adjacent to breast tumour, or fibroadenoma. Sections were immunohistochemically stained for ER alpha, ER beta, and the progesterone receptor. The staining pattern for each antibody was evaluated and compared.
RESULTS: ER alpha was restricted to the cell nuclei of epithelial cells lining ducts and lobules. Although ER beta was also seen in these cells, additional strong staining was detected specifically in the cell nuclei of myoepithelial cells. Occasional staining was seen in surrounding stromal and endothelial cell nuclei and in lymphocytes.
CONCLUSIONS: ER subtypes have distinct distribution patterns in the normal mammary gland. The widespread distribution of ER beta suggests that it may be the dominant ER in the mammary gland where it may be acting as a natural suppressor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986344      PMCID: PMC1769648          DOI: 10.1136/jcp.55.5.371

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  Immunolocalisation of oestrogen receptor beta in human tissues.

Authors:  A H Taylor; F Al-Azzawi
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

2.  Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; J Hewlett; M P Davies; D R Sibson; J P Sloane
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta.

Authors:  J H Krege; J B Hodgin; J F Couse; E Enmark; M Warner; J F Mahler; M Sar; K S Korach; J A Gustafsson; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium.

Authors:  H O Critchley; R M Brenner; T A Henderson; K Williams; N R Nayak; O D Slayden; M R Millar; P T Saunders
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

5.  Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland.

Authors:  V Speirs; I P Adams; D S Walton; S L Atkin
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

6.  Estrogen receptors alpha and beta in the rodent mammary gland.

Authors:  S Saji; E V Jensen; S Nilsson; T Rylander; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland.

Authors:  J Russo; X Ao; C Grill; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1999-02       Impact factor: 4.872

8.  Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers.

Authors:  K Iwao; Y Miyoshi; C Egawa; N Ikeda; S Noguchi
Journal:  Int J Cancer       Date:  2000-12-01       Impact factor: 7.396

9.  The human myoepithelial cell is a natural tumor suppressor.

Authors:  M D Sternlicht; P Kedeshian; Z M Shao; S Safarians; S H Barsky
Journal:  Clin Cancer Res       Date:  1997-11       Impact factor: 12.531

10.  Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

Authors:  M Saegusa; I Okayasu
Journal:  Jpn J Cancer Res       Date:  2000-05
View more
  46 in total

1.  Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.

Authors:  Guojun Cheng; Zhang Weihua; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

Review 2.  Steroid receptors and cell cycle in normal mammary epithelium.

Authors:  Elizabeth Anderson; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  ERβ expression and breast cancer risk prediction for women with atypias.

Authors:  Tina J Hieken; Jodi M Carter; John R Hawse; Tanya L Hoskin; Melanie Bois; Marlene Frost; Lynn C Hartmann; Derek C Radisky; Daniel W Visscher; Amy C Degnim
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

4.  TP53 Status and Estrogen Receptor-Beta in Triple-Negative Breast Cancer: Company Matters.

Authors:  Sunil S Badve; Yesim Gökmen-Polar
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

5.  Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

Authors:  Hakeemah Al-Nakhle; Philip A Burns; Michele Cummings; Andrew M Hanby; Thomas A Hughes; Sampoorna Satheesha; Abeer M Shaaban; Laura Smith; Valerie Speirs
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 6.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 7.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

8.  The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.

Authors:  L Nakopoulou; A C Lazaris; E G Panayotopoulou; I Giannopoulou; N Givalos; S Markaki; A Keramopoulos
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

9.  Controlled ovarian stimulation therapy as a potential risk for the development and progression of renal cell carcinomas: A case report and literature review.

Authors:  Sotirios G Doukas; Boris Martinez; Marnie E Rosenthal; Dimitra P Vageli
Journal:  Mol Clin Oncol       Date:  2021-05-23

Review 10.  Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.

Authors:  C K Osborne; A Wakeling; R I Nicholson
Journal:  Br J Cancer       Date:  2004-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.